That's my target
They have more than that in cash and A/R. My guess is the stock will flounder around here until next news .. maybe an SPR announcement in January or earnings in Feb. Either way, its probably dead money at best.
they guided revenue up next quarter, and with hpv coming in soon seems like revenue has bottomed